Use of Biological Resources · 6 question types
Past paper frequency (2018 to 2024)
This topic accounts for approximately 10% of your exam marks.
Insulin production by bacteria and GM crops are growing in exam frequency.
The classic example of genetic engineering, and the first to be commercialised in 1982, is the production of human insulin for treating people with type 1 diabetes. Before genetic engineering, diabetics had to use insulin extracted from cow or pig pancreases, which was expensive, in short supply, and slightly different from human insulin (some patients developed allergic reactions).
Applying the general five-step process specifically to insulin:
Explaining how GM bacteria are produced (4-mark question)
What comes up: "Explain how genetically modified bacteria are produced" — typically 4 marks, so you need four distinct credited points.
Write (four marks): (1) A restriction enzyme is used to cut the human insulin gene out of human DNA (producing sticky ends). (2) The same restriction enzyme is used to cut open a bacterial plasmid, producing complementary sticky ends. (3) DNA ligase joins the insulin gene into the plasmid, forming a recombinant plasmid. (4) The recombinant plasmid is inserted into a bacterium (the bacterium is transformed).
Watch out: you do not earn a mark just for saying "the bacteria are grown in a fermenter" unless the question specifically asks about insulin production at scale. The four-mark version targets the gene-cutting and joining steps. If the question asks for a fifth point, add: bacteria are cultured and the insulin is extracted and purified.
Bacteria are the workhorse of genetic engineering for several reasons:
Today, almost all of the world's medical insulin is made by GM bacteria using exactly this process. The insulin produced is chemically identical to human insulin, with no risk of allergic reaction. It can be made in unlimited quantities at low cost. This was one of the great medical successes of the late 20th century.
Other proteins made by GM bacteria include human growth hormone, blood-clotting factors for haemophilia patients, and several vaccines.